PyInvesting

Market research

GLPG.AS Galapagos NV

Former ticker of LKFT.AS · through May 7, 2026

AS EUR Healthcare

Latest close

26.80 —

As of Aug 7, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
2B
P/E ratio
2.52
Analyst target
31.4571
Dividend yield
Not available
Beta
0.01

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Galapagos NV is currently in a long term downtrend where the price is trading 29.9% below its 200 day moving average.

From a valuation standpoint, the stock is 243.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 9.2.

Galapagos NV's total revenue rose by 0.7% to $144M since the same quarter in the previous year.

Its net income has increased by 49.9% to $-58M since the same quarter in the previous year.

Finally, its free cash flow grew by 49.9% to $-83M since the same quarter in the previous year.

Based on the above factors, Galapagos NV gets an overall score of 3/5.